» Articles » PMID: 16377867

Rapid and Quantitative Detection of Crimean-Congo Hemorrhagic Fever Virus by One-step Real-time Reverse Transcriptase-PCR

Overview
Date 2005 Dec 27
PMID 16377867
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

In this article, the development of a new TaqMan-based one-step real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay for detection and quantification of Crimean-Congo hemorrhagic fever virus (CCHFV) RNA is described. Selected oligos targeting the highly conserved S region of CCHFV were designed by using our oligo design and analysis software, Oligoware 1.0. None of the primer sequences showed genomic cross-reactivity with other viruses or cells in a BLAST (NCBI) search analysis. The sensitivity and specificity of the primers and the probe were tested using 18 serum samples from patients from East Anatolian who were suspected of having CCHFV, including 2 samples that had already been confirmed to be positive for CCHFV. Among the 16 previously unconfirmed samples, 5 were positive by TaqMan-based one-step real-time RT-PCR and 1 was positive by non-nested RT-PCR, and these results were confirmed with DNA sequencing analysis. The 2 previously confirmed CCHFV RNA samples were also positive by both TaqMan-based one-step real-time RT-PCR and non-nested RT-PCR tests. To ensure the quantitative reproducibility of TaqMan-based one-step real-time RT-PCR, the procedure was repeated several times and the same results were obtained (SD = 0.84 [maximum value]). The developed assay was able to sensitively quantify the concentration of CCHFV RNA, which ranged from 10(2) to 10(7) copies/ml per reaction, using plasmid standards generated from the CCHFV RNA (correlation coefficiency = 0.989). The results of the one-step real-time RT-PCR assay were more sensitive than those of the non-nested RT-PCR assay. It can be concluded that our one-step real-time RT-PCR assay is a reliable, reproducible, specific, sensitive and simple tool for the detection and quantification of CCHFV.

Citing Articles

Evolving Landscape of Emerging Virus Diagnosis: Challenges and Innovations.

Kumar A, Saini S, Anvikar A, Mishra N, Misra G Mol Biotechnol. 2025; .

PMID: 40042766 DOI: 10.1007/s12033-025-01385-w.


Recent Advances in Crimean-Congo Hemorrhagic Fever Virus Detection, Treatment, and Vaccination: Overview of Current Status and Challenges.

Muzammil K, Rayyani S, Abbas Sahib A, Gholizadeh O, Sameer H, Jwad Kazem T Biol Proced Online. 2024; 26(1):20.

PMID: 38926669 PMC: 11201903. DOI: 10.1186/s12575-024-00244-3.


Effects of aurantiamide on a rat model of renovascular arterial hypertension.

Aslan M, Basrali F, Ulker P, Barut Z, Yilmaz C, Ceker T Pflugers Arch. 2023; 475(10):1177-1192.

PMID: 37582694 PMC: 10499692. DOI: 10.1007/s00424-023-02850-8.


A Novel RT-LAMP for the Detection of Different Genotypes of Crimean-Congo Haemorrhagic Fever Virus in Patients from Spain.

Febrer-Sendra B, Fernandez-Soto P, Diego J, Crego-Vicente B, Negredo A, Munor-Bellido J Int J Mol Sci. 2023; 24(7).

PMID: 37047384 PMC: 10094476. DOI: 10.3390/ijms24076411.


Crimean-Congo Hemorrhagic Fever: Current Scenario in India.

Yadav P, Raut C, Patil D, Majumdar T, Mourya D Proc Natl Acad Sci India Sect B Biol Sci. 2020; 84(1):9-18.

PMID: 32226205 PMC: 7100343. DOI: 10.1007/s40011-013-0197-3.